Inventor · disambiguated record
Neil H. Bander
Also filed as: BANDER NEIL · BANDER NEIL H
25 granted patents·28 pending applications·1,375 citations·filing 1984–2025
97Inventor score
Files withUNIV CORNELL20CORNELL RES FOUNDATION INC18BANDER NEIL H4SLOAN KETTERING INST CANCER3UNIV COLUMBIA2
Top patents by PatentIndex Score
53 records- 0198US7192586B2Methods and compositions for treating or preventing skin disorders using binding agents specific for prostate specific membrane antigenCORNELL RES FOUNDATION INC·Filed 2002·Granted Mar 20, 2007·200 cites·62 claims
- 0298US7163680B2Treatment and diagnosis of cancerCORNELL RES FOUNDATION INC·Filed 2001·Granted Jan 16, 2007·96 cites·43 claims
- 0397US7666414B2Methods for treating prostate cancer using modified antibodies to prostate-specific membrane antigenCORNELL RES FOUNDATION INC·Filed 2005·Granted Feb 23, 2010·48 cites·52 claims
- 0497US6107090ATreatment and diagnosis of prostate cancer with antibodies to extracellur PSMA domainsCORNELL RES FOUNDATION INC·Filed 1997·Granted Aug 22, 2000·174 cites·60 claims
- 0596US7514078B2Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodiesCORNELL RES FOUNDATION INC·Filed 2003·Granted Apr 7, 2009·75 cites·140 claims
- 0696US6136311ATreatment and diagnosis of cancerCORNELL RES FOUNDATION INC·Filed 1997·Granted Oct 24, 2000·120 cites·22 claims
- 0795US12285503B2Methods and reagents for tumor targeting with greater efficacy and less toxicityUNIV CORNELL·Filed 2023·Granted Apr 29, 2025·1 cites·19 claims
- 0895US11738101B2Methods and reagents for tumor targeting with greater efficacy and less toxicityUNIV CORNELL·Filed 2021·Granted Aug 29, 2023·2 cites·21 claims
- 0995US7045605B2Modified antibodies to prostate-specific membrane antigen and uses thereofCORNELL RES FOUNDATION INC·Filed 2002·Granted May 16, 2006·80 cites·142 claims
- 1095US6767711B2Treatment and diagnosis of prostate cancerCORNELL RES FOUNDATION INC·Filed 2001·Granted Jul 27, 2004·61 cites·28 claims
- 1192US11491247B2Methods and reagents for tumor targeting with greater efficacy and less toxicityUNIV CORNELL·Filed 2018·Granted Nov 8, 2022·3 cites·59 claims
- 1291US6770450B1Treatment and diagnosis of cancerCORNELL RES FOUNDATION INC·Filed 1999·Granted Aug 3, 2004·50 cites·49 claims
- 1388US6649163B1Treatment and diagnosis of cancerCORNELL RES FOUNDATION INC·Filed 1999·Granted Nov 18, 2003·51 cites·109 claims
- 1487US7666425B1Treatment and diagnosis of prostate cancerCORNELL RES FOUNDATION INC·Filed 1999·Granted Feb 23, 2010·51 cites·50 claims
- 1586US2025230259A1Androgen suppression, prostate-specific membrane antigen and the concept of conditionally enhanced vulnerabilityUNIV CORNELL·Filed 2024·Application pending·0 cites
- 1685US5773292AAntibodies binding portions, and probes recognizing an antigen of prostate epithelial cells but not antigens circulating in the bloodCORNELL RES FOUNDATION INC·Filed 1995·Granted Jun 30, 1998·69 cites·19 claims
- 1785US2025058000A1Treatment of Proliferative Disorders Using Antibodies to PSMAUNIV CORNELL·Filed 2024·Application pending·0 cites
- 1883US8951737B2Treatment and diagnosis of cancerBANDER NEIL H·Filed 2007·Granted Feb 10, 2015·5 cites·28 claims
- 1981US4713352AMonoclonal antibody panel for early diagnosis and therapy of renal carcinomaSLOAN KETTERING INST CANCER·Filed 1984·Granted Dec 15, 1987·36 cites·5 claims
- 2079US2025249132A1Methods and reagents for tumor targeting with greater efficacy and less toxicityUNIV CORNELL·Filed 2025·Application pending·0 cites
- 2178US7112412B1Treatment and diagnosis of prostate cancerCORNELL RES FOUNDATION INC·Filed 1999·Granted Sep 26, 2006·39 cites·51 claims
- 2278US6653129B1Method for isolation of cells from a solutionUNIV COLORADO·Filed 2000·Granted Nov 25, 2003·19 cites·16 claims
- 2374US6299598B1Drainage catheterCOOK UROLOGICAL INC·Filed 1998·Granted Oct 9, 2001·149 cites·19 claims
- 2470US2006275212A1Treatment and diagnosis of cancerCORNELL RES FOUNDATION INC A N·Filed 2006·Application pending·0 cites
- 2566US6087098AEnhanced reverse transcriptase polymerase chain assay to detect MN in patients with renal cell carcinomaUNIV COLUMBIA·Filed 1997·Granted Jul 11, 2000·32 cites·6 claims
- 2666US2022323618A1Methods and kits for diagnosis of cancer and prediction of therapeutic valueUNIV CORNELL·Filed 2022·Application pending·0 cites
- 2765US2020282085A1Methods and kits for diagnosis of cancer and prediction of therapeutic valueUNIV CORNELL·Filed 2019·Application pending·0 cites
- 2865US2010291113A1Treatment of Proliferative Disorders Using Antibodies to PSMAUNIV CORNELL·Filed 2008·Application pending·0 cites
- 2963US2004105865A1Treatment and diagnosis of prostate cancerCORNELL RES FOUNDATION INC·Filed 2003·Application pending·0 cites
- 3063US2015056135A1Treatment of Proliferative Disorders Using Antibodies to PSMAUNIV CORNELL·Filed 2014·Application pending·0 cites
- 3163US2009280120A1Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodiesBANDER NEIL H·Filed 2009·Application pending·0 cites
- 3261US2019070322A1Treatment of Proliferative Disorders Using Antibodies to PSMAUNIV CORNELL·Filed 2018·Application pending·0 cites
- 3361US2025345420A1Cancer immunotherapies to promote hyperacute rejectionUNIV CORNELL·Filed 2023·Application pending·0 cites
- 3461US2015316553A1Treatment and diagnosis of cancerCORNELL RES FOUNDATION INC·Filed 2015·Application pending·0 cites
- 3560US2013225541A1Elevated PSMA Identifies Lethal Prostate CancersUNIV CORNELL·Filed 2013·Application pending·0 cites
- 3659US2018088120A1Elevated PSMA Identifies Lethal Prostate CancersUNIV CORNELL·Filed 2017·Application pending·0 cites
- 3758US2023364271A1Methods and compositions for increasing uptake, internalization, and/or retention of small molecule ligandsUNIV CORNELL·Filed 2021·Application pending·0 cites
- 3858US2003003101A1Treatment and diagnosis of prostate cancerCORNELL RES FOUNDATION INC·Filed 2001·Application pending·0 cites
- 3957US2024000979A1Methods and compositions for synergistic uptake and retention of small molecule ligandsUNIV CORNELL·Filed 2021·Application pending·0 cites
- 4056US2014099257A1Androgen Suppression, Prostate-Specific Membrane Antigen and the Concept of Conditionally Enhanced VulnerabilityUNIV CORNELL·Filed 2013·Application pending·0 cites
- 4155US2018208676A1Androgen Suppression, Prostate-Specific Membrane Antigen and the Concept of Conditionally Enhanced VulnerabilityUNIV CORNELL·Filed 2017·Application pending·0 cites
- 4254US2018118847A1Modifield antibodies to prostate-specific membrane antigen and uses thereofCORNELL RES FOUNDATION INC·Filed 2017·Application pending·0 cites
- 4354US2004136998A1Methods and compositions for treating or preventing insulin-related disorders using binding agents specific for prostate specific membrane antigenFiled 2003·Application pending·0 cites
- 4453US2024000959A1Cancer immunotherapies to promote hyperacute rejectionUNIV CORNELL·Filed 2021·Application pending·0 cites
- 4550US10517969B2Methods and kits for diagnosis of cancer and prediction of therapeutic valueBANDER NEIL H·Filed 2010·Granted Dec 31, 2019·0 cites·9 claims
- 4649US2010278726A1Modified Antibodies to Prostate-Specific Membrane Antigen and Uses ThereofCORNELL RES FOUNDATION INC·Filed 2010·Application pending·0 cites
- 4748US2017037142A1Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodiesBANDER NEIL H·Filed 2016·Application pending·0 cites
- 4844US2004087017A1Method for isolation of cells from a solutionFiled 2003·Application pending·0 cites
- 4943US2013315830A1PSMA as a BioMarker for Androgen Activity in Prostate CancerUNIV CORNELL·Filed 2013·Application pending·0 cites
- 5040US2003007974A1Endopeptidase/anti-PSMA antibody fusion proteins for treatment of cancerFiled 2002·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Neil H. Bander files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →